As demonstrated in a previous model-based simulation study (König and Holzhütter, 2012), exposing the permanently glucose-releasing “starved” liver of the diabetic patient to a rigorous insulin treatment at persistently elevated glucagon level may increase the risk of severe hypoglycaemia. The gene discussed is INS; the disease is Hypoglycemia.